NATERA, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
NATERA, INC. (NTRA) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $102.09 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-07
- NATERA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $102.09M, a 8.44% increase year-over-year.
- NATERA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $94.07M, a 19.94% increase year-over-year.
- NATERA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $93.21M, a 28.63% increase year-over-year.
- NATERA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $91.52M, a 28.38% increase year-over-year.
- NATERA, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $357.30M, a 29.13% increase from fiscal 2024.
- NATERA, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $276.69M, a 43.78% increase from fiscal 2023.
- NATERA, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $192.44M, a 26.28% increase from fiscal 2022.
- NATERA, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $152.38M, a 32.26% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $102.09M 10-Q · filed 2026-08-07 | $196.16M 10-Q · filed 2026-08-07 | $289.37M derived: sum of 3 quarters · filed 2026-08-07 | $380.88M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $94.07M 10-Q · filed 2026-05-08 | $187.28M derived: sum of 2 quarters · filed 2026-05-08 | $278.80M derived: sum of 3 quarters · filed 2026-05-08 | $372.94M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $93.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $184.72M derived: sum of 2 quarters · filed 2026-02-27 | $278.87M derived: sum of 3 quarters · filed 2026-08-07 | $357.30M 10-K · filed 2026-02-27 |
| 2025-09-30 | $91.52M 10-Q · filed 2025-11-07 | $185.66M derived: sum of 2 quarters · filed 2026-08-07 | $264.10M 10-Q · filed 2025-11-07 | $336.56M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $94.15M 10-Q · filed 2026-08-07 | $172.58M 10-Q · filed 2026-08-07 | $245.04M derived: sum of 3 quarters · filed 2026-08-07 | $316.33M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $78.44M 10-Q · filed 2026-05-08 | $150.90M derived: sum of 2 quarters · filed 2026-05-08 | $222.18M derived: sum of 3 quarters · filed 2026-05-08 | $290.17M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $72.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $143.74M derived: sum of 2 quarters · filed 2026-02-27 | $211.74M derived: sum of 3 quarters · filed 2026-02-27 | $276.69M 10-K · filed 2026-02-27 |
| 2024-09-30 | $71.28M 10-Q · filed 2025-11-07 | $139.28M derived: sum of 2 quarters · filed 2025-11-07 | $204.23M 10-Q · filed 2025-11-07 | $253.77M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $68.00M 10-Q · filed 2025-08-08 | $132.95M 10-Q · filed 2025-08-08 | $182.49M derived: sum of 3 quarters · filed 2026-02-27 | $240.22M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $64.95M 10-Q · filed 2025-05-09 | $114.49M derived: sum of 2 quarters · filed 2026-02-27 | $172.22M derived: sum of 3 quarters · filed 2026-02-27 | $216.69M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $49.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $107.27M derived: sum of 2 quarters · filed 2026-02-27 | $151.74M derived: sum of 3 quarters · filed 2026-02-27 | $192.44M 10-K · filed 2026-02-27 |
| 2023-09-30 | $57.73M 10-Q · filed 2024-11-12 | $102.20M derived: sum of 2 quarters · filed 2024-11-12 | $142.90M 10-Q · filed 2024-11-12 | $178.88M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $44.47M 10-Q · filed 2024-08-09 | $85.17M 10-Q · filed 2024-08-09 | $121.15M derived: sum of 3 quarters · filed 2025-02-28 | $161.49M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $40.70M 10-Q · filed 2024-05-10 | $76.68M derived: sum of 2 quarters · filed 2025-02-28 | $117.02M derived: sum of 3 quarters · filed 2025-02-28 | $157.99M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $35.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $76.32M derived: sum of 2 quarters · filed 2025-02-28 | $117.30M derived: sum of 3 quarters · filed 2025-02-28 | $152.38M 10-K · filed 2025-02-28 |
| 2022-09-30 | $40.34M 10-Q · filed 2023-11-09 | $81.31M derived: sum of 2 quarters · filed 2023-11-09 | $116.40M 10-Q · filed 2023-11-09 | $146.82M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $40.97M 10-Q · filed 2023-08-04 | $76.06M 10-Q · filed 2023-08-04 | $106.48M derived: sum of 3 quarters · filed 2024-02-29 | $132.94M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $35.09M 10-Q · filed 2023-05-10 | $65.51M derived: sum of 2 quarters · filed 2024-02-29 | $91.97M derived: sum of 3 quarters · filed 2024-02-29 | $127.07M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $30.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $56.88M derived: sum of 2 quarters · filed 2024-02-29 | $91.98M derived: sum of 3 quarters · filed 2024-02-29 | $115.22M 10-K · filed 2024-02-29 |
| 2021-09-30 | $26.46M 10-Q · filed 2022-11-09 | $61.56M derived: sum of 2 quarters · filed 2022-11-09 | $84.80M 10-Q · filed 2022-11-09 | $100.56M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $35.10M 10-Q · filed 2022-08-05 | $58.34M 10-Q · filed 2022-08-05 | $74.10M derived: sum of 3 quarters · filed 2023-03-01 | $89.13M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $23.23M 10-Q · filed 2022-05-06 | $39.00M derived: sum of 2 quarters · filed 2023-03-01 | $54.03M derived: sum of 3 quarters · filed 2023-03-01 | $65.99M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $15.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $30.80M derived: sum of 2 quarters · filed 2023-03-01 | $42.75M derived: sum of 3 quarters · filed 2023-03-01 | $50.17M 10-K · filed 2023-03-01 |
| 2020-09-30 | $15.03M 10-Q · filed 2021-11-05 | $26.99M derived: sum of 2 quarters · filed 2021-11-05 | $34.41M 10-Q · filed 2021-11-05 | $42.93M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $11.96M 10-Q · filed 2021-08-06 | $19.37M 10-Q · filed 2021-08-06 | $27.90M derived: sum of 3 quarters · filed 2022-02-25 | $38.14M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $7.42M 10-Q · filed 2021-05-07 | $15.94M derived: sum of 2 quarters · filed 2022-02-25 | $26.19M derived: sum of 3 quarters · filed 2022-02-25 | $31.99M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $8.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $18.77M derived: sum of 2 quarters · filed 2022-02-25 | $24.57M derived: sum of 3 quarters · filed 2022-02-25 | $28.62M 10-K · filed 2022-02-25 |
| 2019-09-30 | $10.25M 10-Q · filed 2020-11-06 | $16.05M derived: sum of 2 quarters · filed 2020-11-06 | $20.10M 10-Q · filed 2020-11-06 | $24.16M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $5.80M 10-Q · filed 2020-08-07 | $9.86M 10-Q · filed 2020-08-07 | $13.91M derived: sum of 3 quarters · filed 2021-02-26 | $17.53M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $4.05M 10-Q · filed 2020-05-08 | $8.11M derived: sum of 2 quarters · filed 2021-02-26 | $11.73M derived: sum of 3 quarters · filed 2021-02-26 | $15.10M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $7.68M derived: sum of 2 quarters · filed 2021-02-26 | $11.04M derived: sum of 3 quarters · filed 2021-02-26 | $14.20M 10-K · filed 2021-02-26 |
| 2018-09-30 | $3.62M 10-Q · filed 2019-11-08 | $6.98M derived: sum of 2 quarters · filed 2019-11-08 | $10.14M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $3.37M 10-Q · filed 2019-08-09 | $6.52M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $3.15M 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | $11.40M 10-K · filed 2019-03-15 | |||
| 2016-12-31 | $10.60M 10-K · filed 2019-03-15 | |||
| 2015-12-31 | $7.33M 10-K · filed 2018-03-15 | |||
| 2014-12-31 | $5.16M 10-K · filed 2017-03-16 | |||
| 2013-12-31 | $1.66M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |